Protein,Protein_definition,Disease_category,Disease,Method,Nb_SNP,OR[95%CI],P_value
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",Inverse variance weighted,75,1.14 [1.07-1.23],0.0001081922774327
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,Inverse variance weighted,75,1.00 [0.98-1.02],0.972170854363223
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,Inverse variance weighted,75,1.15 [0.93-1.43],0.194196526952908
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,Inverse variance weighted,75,1.00 [0.97-1.04],0.820200147847996
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,Inverse variance weighted,75,0.83 [0.63-1.10],0.204820536942778
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,Inverse variance weighted,75,0.99 [0.96-1.02],0.598136523261737
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",Inverse variance weighted,75,0.99 [0.93-1.06],0.807445467193906
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",Inverse variance weighted,75,0.96 [0.93-1.00],0.0257489010437188
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,Inverse variance weighted,75,1.01 [0.99-1.03],0.488219333802013
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,Inverse variance weighted,75,1.01 [0.99-1.03],0.404218331508492
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,Inverse variance weighted,75,0.99 [0.98-1.01],0.373303932136606
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,Inverse variance weighted,75,0.98 [0.96-1.00],0.0148784225518236
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,Inverse variance weighted,75,0.93 [0.87-1.00],0.0384575373412826
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",Inverse variance weighted,75,0.98 [0.96-1.00],0.0883516257779226
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,Inverse variance weighted,75,1.00 [0.97-1.03],0.854949370740975
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,Inverse variance weighted,75,1.00 [0.98-1.02],0.763913823366033
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,Inverse variance weighted,75,0.99 [0.96-1.01],0.22078925801173
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",Inverse variance weighted,75,1.00 [0.98-1.03],0.832179824321835
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,"Hypertension, essential",Inverse variance weighted,75,1.01 [0.99-1.02],0.5221552684452
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Hypertension,Inverse variance weighted,75,1.00 [0.98-1.02],0.983033684256033
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,Inverse variance weighted,75,0.99 [0.87-1.13],0.868156701164552
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,Inverse variance weighted,75,0.99 [0.96-1.01],0.295888238734198
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,Inverse variance weighted,75,0.94 [0.87-1.02],0.125874078310985
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",Inverse variance weighted,75,0.99 [0.97-1.02],0.524358283213287
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,Inverse variance weighted,75,1.00 [0.95-1.05],0.966947506572189
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",Inverse variance weighted,75,0.99 [0.97-1.01],0.519185643198948
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,Inverse variance weighted,75,0.98 [0.96-1.00],0.0226766536086246
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,Inverse variance weighted,75,0.99 [0.97-1.02],0.548413506810817
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Other diseases of liver,Inverse variance weighted,75,1.00 [0.95-1.05],0.899429196724107
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,Inverse variance weighted,75,1.02 [0.99-1.05],0.287479321530389
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Other diseases of intestines,Inverse variance weighted,75,0.98 [0.97-1.00],0.0568198621805101
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Diseases of liver,Inverse variance weighted,75,0.99 [0.96-1.03],0.644677868313815
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",Inverse variance weighted,75,1.01 [0.99-1.03],0.217051991043191
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,Inverse variance weighted,75,1.01 [0.97-1.06],0.539459808558708
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,Inverse variance weighted,75,0.98 [0.96-1.01],0.126717453028513
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,Inverse variance weighted,75,1.00 [0.99-1.02],0.572455119096077
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",Inverse variance weighted,75,1.00 [0.99-1.02],0.598521037959769
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,Inverse variance weighted,75,1.01 [0.99-1.02],0.46872951626996
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,Inverse variance weighted,75,1.01 [0.98-1.04],0.466601130025354
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,Inverse variance weighted,75,0.99 [0.98-1.01],0.482465669876228
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",Inverse variance weighted,75,1.00 [0.98-1.01],0.598827771247651
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,Inverse variance weighted,75,1.00 [0.98-1.02],0.871874724036121
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,Inverse variance weighted,75,1.00 [0.97-1.02],0.857835059882525
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,Inverse variance weighted,75,0.98 [0.95-1.02],0.266927652991423
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,Inverse variance weighted,75,1.00 [0.96-1.05],0.946767790590331
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,Inverse variance weighted,75,0.99 [0.95-1.03],0.467946732336163
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,Inverse variance weighted,75,1.00 [0.94-1.06],0.981697443749512
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,Inverse variance weighted,75,1.01 [0.99-1.03],0.521353138267677
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,Inverse variance weighted,75,1.02 [0.95-1.09],0.560009098501711
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,Inverse variance weighted,75,0.98 [0.92-1.04],0.458547664335466
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",Inverse variance weighted,75,0.97 [0.92-1.01],0.122922666110439
